Fluticasone propionate improves quality of life in patients with asthma requiring oral corticosteroids. (Q53624302)

16 May 2018

title

Fluticasone propionate improves quality of life in patients with asthma requiring oral corticosteroids. (English)

1 reference

16 May 2018

0 references

1 reference

fluticasone propionate

1 reference

inferred from title

author

Bennett P. deBoisblanc

3

object named as

DeBoisblanc BP

1 reference

16 May 2018

author name string

Okamoto LJ

1

1 reference

16 May 2018

Noonan M

2

1 reference

16 May 2018

Kellerman DJ

4

1 reference

16 May 2018

publication date

1 May 1996

1 reference

16 May 2018

Annals of Allergy, Asthma & Immunology

published in

1 reference

16 May 2018

volume

76

1 reference

16 May 2018

issue

5

1 reference

16 May 2018

page(s)

455-461

1 reference

16 May 2018

Measuring health-related quality of life

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963463-1

7 January 2021

The human pharmacology of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963463-1

7 January 2021

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963463-1

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963463-1

7 January 2021

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963463-1

7 January 2021

Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963463-1

7 January 2021

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963463-1

7 January 2021

Measuring quality of life in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963463-1

7 January 2021

A life activities questionnaire for adult asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963463-1

7 January 2021

The Living with Asthma Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963463-1

7 January 2021

Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963463-1

7 January 2021

10.1016/S1081-1206(10)63463-1

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018